These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32478743)

  • 1. Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis.
    Okurowska K; Roy S; Thokala P; Partridge L; Garg P; MacNeil S; Monk PN; Karunakaran E
    J Vis Exp; 2020 May; (159):. PubMed ID: 32478743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
    Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
    Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Activity of Poly-epsilon-lysine Peptide Hydrogels Against Pseudomonas aeruginosa.
    Kennedy SM; Deshpande P; Gallagher AG; Horsburgh MJ; Allison HE; Kaye SB; Wellings DA; Williams RL
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):18. PubMed ID: 32776141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies.
    Zhu H; Kochevar IE; Behlau I; Zhao J; Wang F; Wang Y; Sun X; Hamblin MR; Dai T
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):586-593. PubMed ID: 28129422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 7. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.
    Clemens LE; Jaynes J; Lim E; Kolar SS; Reins RY; Baidouri H; Hanlon S; McDermott AM; Woodburn KW
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6273-6281. PubMed ID: 29242901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tolerance to commonly used antibiotics in a
    Okurowska K; Monk PN; Karunakaran E
    Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739119
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model.
    Frucht-Pery J; Golan G; Hemo I; Zauberman H; Shapiro M
    Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):532-4. PubMed ID: 8537030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melimine-Coated Antimicrobial Contact Lenses Reduce Microbial Keratitis in an Animal Model.
    Dutta D; Vijay AK; Kumar N; Willcox MD
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5616-5624. PubMed ID: 27768798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo rabbit and human corneas as models for bacterial and fungal keratitis.
    Pinnock A; Shivshetty N; Roy S; Rimmer S; Douglas I; MacNeil S; Garg P
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):333-342. PubMed ID: 27844206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel murine model for contact lens wear reveals clandestine IL-1R dependent corneal parainflammation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa.
    Metruccio MME; Wan SJ; Horneman H; Kroken AR; Sullivan AB; Truong TN; Mun JJ; Tam CKP; Frith R; Welsh L; George MD; Morris CA; Evans DJ; Fleiszig SMJ
    Ocul Surf; 2019 Jan; 17(1):119-133. PubMed ID: 30439473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM; Conerly LL; Hume EB; Dajcs JJ; Girgis DO; Cannon BM; Thibodeaux BA; Stroman DW; O'Callaghan RJ
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Pseudomonas keratitis in humans.
    Hessburg PC
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):896-903. PubMed ID: 16874993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses.
    Hui A; Willcox M; Jones L
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4896-904. PubMed ID: 25028363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation.
    Mattila JS; Korsbäck A; Krootila K; Holopainen JM
    Acta Ophthalmol; 2013 Aug; 91(5):e410-1. PubMed ID: 23844860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.